BEAUTYFARM MED(02373.HK)

Company Encyclopedia
View More
name
BEAUTYFARM MED
02373.HK
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People’s Republic of China. It offers traditional beauty, aesthetic medical, subhealth assessment; and intervention services. The company markets its products under the Beauty Farm, Palaispa, Neology, and CellCare brand names.
36.02 B
02373.HKMarket value -Rank by Market Cap -/-

Financial Score

02/01/2026 Update
B
Specialized Consumer ServicesIndustry
Industry Ranking1/29
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE31.42%A
    • Profit Margin9.29%B
    • Gross Margin49.33%B
  • Growth ScoreA
    • Revenue YoY29.03%A
    • Net Profit YoY22.75%B
    • Total Assets YoY28.80%A
    • Net Assets YoY8.64%B
  • Cash ScoreB
    • Cash Flow Margin1076.77%B
    • OCF YoY29.03%A
  • Operating ScoreB
    • Turnover0.75B
  • Debt ScoreE
    • Gearing Ratio78.45%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Beauty Farm Medical & Health Industry, Inc. (2373) Gets a Buy from First Shanghai Securities

    In a report released yesterday, from First Shanghai Securities maintained a Buy rating on Beauty Farm Medical & Health Industry, Inc., with a price target of HK$43.70.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge-fund level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Currently, the analyst consensus on Beauty Farm Medical & Health Industry, Inc. is a Strong Buy with an average price target of HK$38.49.

    Tip Ranks·
    HK
    02373
    -3.09%
    Tip Ranks·
    HK
    02373
    -3.09%

    Beauty Farm Medical & Health Industry, Inc. (2373) Receives a Buy from Shenwan Hongyuan

    Shenwan Hongyuan analyst maintained a Buy rating on Beauty Farm Medical & Health Industry, Inc. with a price target of HK$37.13. The company's shares closed at HK$26.36. The analyst consensus is a Strong Buy with an average price target of HK$38.83.

    Tip Ranks·
    HK
    02373
    -3.09%
    Tip Ranks·
    HK
    02373
    -3.09%

    BEAUTYFARM MED non-executive director increased holdings by 21,000 shares

    BEAUTYFARM MED announced that on December 2nd, non-executive director Li Fangyu increased the company's share capital by 21,000 shares

    AASTOCKS·
    HK
    02373
    -3.09%
    AASTOCKS·
    HK
    02373
    -3.09%

    Top 10 HK Stock Gainers (12.2)

    QUANTGROUP(02685) rose 25.22%, with a trading turnover 31.5 Million HKD, and a year-to-date rose 147.8%. YUNJI(02670) rose 11.18%, with a trading turnover 39.0 Million HKD, and a year-to-date rose 61.2%. CONANT OPTICAL(02276) rose 10.58%, with a trading turnover 285.1 Million HKD, and a year-to-date rose 123.3%.

    LB Select·
    HK
    02685
    +0.45%
    HK
    02670
    +0.92%
    HK
    02276
    +0.19%
    LB Select·
    HK
    02685
    +0.45%
    HK
    02670
    +0.92%
    HK
    02276
    +0.19%

    BEAUTYFARM MED repurchased 80,000 shares for a total amount of 2.01 million yuan

    BEAUTYFARM MED announced that on November 28, it repurchased 80,000 shares in the market at an average price of 25.09 yuan per share, with a total transaction amount of approximately 2.01 million yuan. To date, the company has repurchased a total of 695,000 shares, with a total consideration of approximately 20.69 million yuan

    AASTOCKS·
    HK
    02373
    -3.09%
    AASTOCKS·
    HK
    02373
    -3.09%
    © 2026 Longbridge｜Disclaimer